During 2026, the trade name for MEDTOX Diagnostics products will transition to Labcorp Point of Care. While we transition our website, visit the MEDTOX Diagnostics website for all our testing devices.

Labcorp Fentanyl Urine Visual Test

Rapid detection in just 10 minutes

The Labcorp Fentanyl Urine Visual Test is a new FDA-cleared device developed to address the urgent need for rapid testing.
Doctor talking to patient in emergency room

Fast, reliable fentanyl test

The Labcorp Fentanyl Urine Visual Test is designed specifically for use by lab professionals in hospitals, urgent care and emergency departments.

> 96% accuracy

More than 96% accurate in detecting norfentanyl (the primary fentanyl metabolite) in a urine drug test.

Extended detection window

Identifies fentanyl exposure for up to 48 hours, even after fentanyl has cleared and may no longer be detected.

Made in the USA

MEDTOX Diagnostics, a Labcorp company, brings over 30 years of expertise in developing rapid drug tests—manufactured in the US to deliver reliability, quality, and consistent supply availability.

Combatting the opioid epidemic

Synthetic opioids—primarily fentanyl—now account for nearly 70% of opioid-related overdose deaths, according to the CDC. With a potency 50x stronger than heroin and 100x stronger than morphine, even 2 milligrams of fentanyl—less than a grain of salt—can be fatal.

Fentanyl is increasingly found in counterfeit pills and illicit substances like heroin and cocaine, making rapid detection of fentanyl exposure essential for timely intervention and overdose prevention.

Doctors around a patient in the emergency room

Why using fentanyl tests to enable rapid response matters

Supports informed clinical decision making

Fentanyl's high potency often requires repeated naloxone administration. Early detection supports informed clinical decision‑making, patient education and timely care.

Rapid response saves lives

Getting test results in just 10 minutes helps providers quickly identify fentanyl exposure and share overdose-prevention education and access to overdose reversal medications for future situations while the patient is still in care—before discharge or transfer.

Simplifies care

No specialized laboratory equipment is required, enabling more convenient rapid fentanyl testing for patient care.

Enables public health initiatives

Rapid screening enables earlier identification of fentanyl exposure—supporting timely interventions that can reduce repeat overdoses, improve patient outcomes and help prevent overdose related deaths.

Get started with the Labcorp Fentanyl Urine Visual Test today

Join us in the fight against fentanyl-related overdoses. Equip your team with the test they need to respond quickly and effectively.